Related Experiment Video
Updated: Jul 7, 2026

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
Thiosemicarbazones active against Clostridium difficile
Cait Costello1, Tarja Karpanen, Peter A Lambert
1School of Life and Health Sciences, Aston University, Birmingham B4 7ET, UK.
Abstract:
A set of closely related furylidene thiosemicarbazones was prepared and screened against various clinically important Gram-positive bacteria. One compound containing an ethylene spacer and a 5-nitrofuryl group was found to have promising activity against Clostridium difficile.
Related Concept Videos
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
Antifungal Agents
Inhibitors of Gram-positive Cell Wall Synthesis
Drugs for Treatment of Ulcerative Colitis in IBD
